Combs Andrew — SEC Form 4 filings

SEC reporting owner CIK 1825005. 5 Form 4 filings on record with FilingPulse; latest filed 2026-02-05.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2024-03-04 to 2026-02-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Prelude Therapeutics Inc (PRLD)Chief Chemistry Officer53 legs · 163,075 sh · $154,7883

Form 4 filings — Combs Andrew

FiledFormIssuerReported transactionsSource
2026-02-054Prelude Therapeutics Inc (PRLD)Grant/award (A): 230,000 (derivative) @ $0EDGAR
2025-03-274Prelude Therapeutics Inc (PRLD)Purchase (P): 100,000 @ $0.69EDGAR
2025-02-054Prelude Therapeutics Inc (PRLD)Grant/award (A): 175,000 (derivative) @ $0EDGAR
2024-12-264Prelude Therapeutics Inc (PRLD)Purchase (P): 3,075 @ $1.15 · Purchase (P): 60,000 @ $1.37EDGAR
2024-03-044Prelude Therapeutics Inc (PRLD)Grant/award (A): 150,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1825005 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →